Asia Pacific Liposome Drug Delivery Market to Grow at a CAGR of XXXX% to reach US$ XXXX Million from 2020 to 2027

Asia Pacific Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, and Lysolipid Thermally Sensitive Liposome (LTSL) Technology); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, and Photodynamic Therapy), and Country

Publication Month: Sep 2020 | Report Code: TIPRE00014175 | No. of Pages: 147 | Category: Biotechnology | Status: Published
Covid

Asia Pacific liposome drug delivery market is expected to reach US$ 1,562.92 million in 2027 from US$ 759.81 in 2019. The market is estimated to grow with a CAGR of 9.6% from 2020-2027.

Liposomes are small sphere-shaped artificial vesicles synthesized from cholesterol and phospholipids. They have multiple layers and a diameter range of 0.01 to 5.0 um. They also have hydrophilic and hydrophobic properties which help liposomes to encapsulate hydrophobic and hydrophilic drugs to be delivered to targeted body site. Liposomes provide an assured system for targeted drug delivery and thereby is the factor influencing the Liposome Drug Delivery market size growth. Liposomes are widely used for enclosing all types of drug molecules such as acyclovir, chloroquinediphosphate, paclitaxel, tropicamide, and cyclosporine. Liposomes are used as a drug carrier for drug therapy for many diseases since they are biodegradable and biocompatible. Also, they have many therapeutic properties like anticancer drugs, genetic materials, proteins, vaccines, macromolecules, and thus can be encapsulated in liposomes. The scope of the liposome drug delivery market includes product, technology, application, and region.

Japan Liposome Drug Delivery Market Revenue and Forecasts to 2027 (US$ MN)

Get more information on this report :

 

Market Insights

New Developments in Lipid Composition for Stability and Optimization of Drugs

The pharmaceutical and biotechnology companies are exploring alternative compositions with cholesterol as well as new techniques such as nanotechnology to improve the stability and drug release profiles with the help of encapsulation and other techniques. They are using liposomes for the generation of extracellular vesicles by targeted cells. According to the Department of Pharmaceutics, SPER, JamiaHamdard University, New Delhi, India a current research was done to prolong and sustain the release of erythromycin (ERY) by preparing a solid lipid nanoparticles (SLNs)-based gel formulation for the safe and effective treatment of acne. ERY-loaded SLNs were developed, and various process variables were optimized with respect to particle size, zeta potential, and entrapment efficiency using the Taguchi model. The main aim was to develop ERY-loaded SLNs-based gel with the potential to sustain and delay the release of the drug. The developed gel may be suitable for the treatment of acne. Manufacturers in the liposome drug delivery market are ramping up their R&D activities to unlock new lipid compositions and strategies that help to optimize the drug transport and stability of liposomes. Similar experiments for innovative liposome fabrication are likely to offer growth opportunities for the market players to attain a significant position and grow in the liposome drug delivery market—new development lipid composition for stability and optimization of drugs.

 

Product- Based Market Insights

Based on product, the liposome drug delivery market is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, others. The liposomal doxorubicin segment held the largest share of the market in 2019, whereas the liposomal amphotericin B segment is anticipated to register the highest CAGR in the market during the forecast period.

 

Asia Pacific Liposome Drug Delivery Market, by Product – 2019 and 2027

 

Technology- Based Market Insights

Based on technology, the liposome drug delivery market has been segmented into stealth liposome technology, non-PEGylated liposome technology, depofoam liposome technology. The stealth liposome technology segment held the largest share of the market in 2019, and continued to register the highest CAGR in the market during the forecast period.

Application- Based Market Insights

Based on application, the liposome drug delivery market has been segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy. The cancer therapy segment held the largest share of the market in 2019, and continued to register the highest CAGR in the market during the forecast period

 

Strategic Insights

High Rise in Popularity of Liposomes in Drug Delivery

Product launches and approvals are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the liposome drug delivery market adopt the expansion, collaboration, and product launch strategies to enlarge customer base across the world. These strategies allow the players to maintain their brand name globally. For instance, Janssen Biotech, Inc. has given additional funding to support further research under its R&D Collaboration and Option to License Agreement with Dendright Pty Ltd (established by UniQuest, the main commercialization company of The University of Queensland) to develop Dendright's tolerizing immunotherapy for the treatment of patients with rheumatoid arthritis (RA). The collaboration will allow the conduct of a first-in-human safety and tolerability study in the second half of 2017 as a turning point in the development of a new liposomal drug product, DEN-181, which offers the potential to intercept RA at a very early stage.

 

ASIA PACIFIC LIPOSOME DRUG DELIVERY MARKET SEGMENTATION

By Product

  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
  • Others

By Technology

  • Stealth Liposome Technology
  •  Non-PEGylated Liposome Technology
  • DepoFoam Liposome Technology
  • Lysolipid Thermally Sensitive Liposome (LTSL) Technology

By Application

  • Fungal Diseases
  • Cancer Therapy
  • Pain Management
  • Viral Vaccines
  • Photodynamic Therapy

 Companies Mentioned

  • ASTELLAS PHARMA INC.
  • JOHNSON AND JOHNSON SERVICES, INC.
  • LUYE PHARMA GROUP
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Novartis AG
  • IpsenPharma
  • Gilead Sciences, Inc
  • Celsion, Inc.

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia PacificLiposome Drug Delivery Market – By Product

1.3.2        Asia PacificLiposome Drug Delivery Market– By Technology

1.3.3        Asia PacificLiposome Drug Delivery Market – By Application

1.3.4        Asia PacificLiposome Drug Delivery Market – By Geography

2.          Asia PacificLiposome Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Asia PacificLiposome Drug Delivery Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Liposome Drug Delivery Market - Asia Pacific PEST Analysis

4.3        Expert Opinion

5.          Asia PacificLiposome Drug Delivery Market - Key Market Dynamics

5.1        Key Market Drivers

5.1.1        High Incidence Of Chronic Diseases Amongst the Population

5.1.2        An Upsurge In Need For Non-Invasive Drug Delivery Devices

5.1.3        Increasing Investments In R&D For Pharmaceutical Companies

5.2        Key Market Restraints

5.2.1        High Expense in Development of Drug Delivery Systems

5.3        Key Market Opportunities

5.3.1        New Developments in Lipid Composition for Stability and Optimization of Drugs

5.4        Future Trends

5.4.1        High Rise in Popularity of Liposomes in Drug Delivery

5.5        Impact Analysis

6.          Liposome Drug Delivery Market – Asia Pacific Analysis

6.1        Asia PacificLiposome Drug Delivery MarketRevenue Forecasts and Analysis

7.          Asia PacificLiposome Drug Delivery Market Analysis and Forecasts To 2027 – By Product

7.1        Overview

7.2        Asia PacificLiposome Drug Delivery Market, By Product 2019& 2027 (%)

7.3        Liposomal Doxorubicin

7.3.1        Overview

7.3.2        Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.4        Liposomal Paclitaxel

7.4.1        Overview

7.4.2        Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Liposomal Amphotericin B

7.5.1        Overview

7.5.2        Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

7.6        Others

7.6.1        Overview

7.6.2        Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.          Liposome Drug Delivery Market – By Technology

8.1        Overview

8.2        Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

8.3        Stealth Liposome Technology

8.3.1        Overview

8.3.2        Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Non-PEGylated Liposome Technology

8.4.1        Overview

8.4.2        Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.5        DepoFoam Liposome Technology

8.5.1        Overview

8.5.2        DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.6        Lysolipid Thermally Sensitive Liposome (LTSL) Technology

8.6.1        Overview

8.6.2        Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.          Liposome Drug Delivery Market Analysis – By Application

9.1        Overview

9.2        Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

9.3        Fungal Diseases

9.3.1        Overview

9.3.2        Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4        Cancer Therapy

9.4.1        Overview

9.4.2        Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5        Pain Management

9.5.1        Overview

9.5.2        Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.6        Viral Vaccine

9.6.1        Overview

9.6.2        Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.7        Photodynamic Therapy

9.7.1        Overview

9.7.2        Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.       Liposome Drug Delivery Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1     Asia PacificLiposome Drug Delivery MarketRevenue and Forecasts To 2027

10.1.1     Overview

10.1.2     Asia Pacific: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)

10.1.3     Asia Pacific Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4     Asia Pacific Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.5     Asia Pacific Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.6     Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

10.1.7     China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       China Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       China Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       China Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8     Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Japan Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Japan Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Japan Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9     India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       India Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       India Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       India Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.10   South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    South Korea Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.10.3    South Korea Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.10.4    South Korea Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.11   Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Australia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.11.3    Australia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.11.4    Australia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.       Impact Of COVID-19 Pandemic on Asia PacificLiposome Drug Delivery Market

11.1     Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.       Company Profiles

12.1     Takeda Pharmaceutical Company Limited

12.2     Novartis AG

12.3     Luye Pharma Group

12.4     Johnson & Johnson Services, Inc.

12.5     Astellas Pharma Inc.

13.       Appendix

13.1     About the Insight Partners

 


LIST OF TABLES

Table 1.            Asia Pacific Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.            Asia Pacific Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 3.            Asia Pacific Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 4.            China Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.            China Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 6.            China Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.            Japan Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.            Japan Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 9.            Japan Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.         India Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.         India Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.         India Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.         South Korea Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.         South Korea Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 15.         South Korea Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 16.         Australia Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.         Australia Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 18.         Australia Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

LIST OF FIGURES

Figure 1.          Liposome Drug Delivery Market Segmentation

Figure 2.          Asia PacificLiposome Drug Delivery Market Overview

Figure 3.          The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market

Figure 4.          Japan Is Expected to Show Highest Market Share During the Forecast Period

Figure 5.          Liposome Drug Delivery Market - Asia Pacific PEST Analysis

Figure 6.          Liposome Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 7.          Asia PacificLiposome Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.          Asia PacificLiposome Drug Delivery Market, By Product 2019 & 2027 (%)

Figure 9.          Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

Figure 14.        Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

Figure 18.        Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

Figure 19.        Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Asia Pacific: Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

Figure 25.        Asia Pacific Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

Figure 26.        Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

Figure 27.        China: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Japan: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        India: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        South Korea: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Australia: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic In Asia Pacific Country Markets

The List of Companies - Asia Pacific Liposome Drug Delivery Market

  1. ASTELLAS PHARMA INC.
  2. JOHNSON AND JOHNSON SERVICES, INC.
  3. LUYE PHARMA GROUP
  4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
  5. Novartis AG
  6. Ipsen Pharma
  7. Gilead Sciences, Inc
  8. Celsion, Inc.
  • To understand the Asia Pacific liposome drug delivery market landscape and identify market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for mammography systems market.

  • Efficiently plan M&A and partnership deals in Asia Pacific liposome drug delivery market by identifying market segments with the most promising probable sales.

  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific liposome drug delivery  market.

  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region.
TIPRE00014175
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing